Abstract
Aims
To describe the evolution and management over time of scleral necrosis as a complication after radiation therapy for uveal melanomas.
Design
Retrospective nonrandomized case series.
Methods
Twenty-three patients (12 male, 11 female; median age 56.4 years; range, 30–73 years) treated with a single plaque therapy (cobalt-60 (Co60) or iodine-125 (I125) (1.5% of treated patients) or proton beam radiotherapy (0.45% of treated patients) for choroidal or ciliary body melanoma, presenting scleral necrosis as a post-radiation complication, were studied. Tumor characteristics, intraocular pressure, location and size of scleral necrosis were recorded during visits after radiation therapy.
Results
The median maximal tumour base and thickness at diagnosis were 14.6 ± 4.4 mm and 7.2 ± 2.3 mm respectively. Median radiation dose to tumor base and tumor apex was 223 Gy and 88.3 Gy respectively. The mean time of scleral necrosis onset after radiation therapy was 70.4 months (range 11–257 months); the mean scleral necrosis diameter at its onset was 4.4 mm (range 1–10 mm). Out of 23 affected eyes, 17 presented a stability of scleral necrosis; in three cases there was partial regression of scleral necrosis; in two cases there was a progressive extension of scleral necrosis until a pre-perforation stade. In two cases, a secondary enucleation was necessary due to a severe neovascular glaucoma.
Conclusions
Scleral necrosis is a rare complication of radiotherapy for uveal melanomas. Relapse with extrascleral extension of the primary tumor has to be ruled out in order to avoid unnecessary enuclations. In most patients, the scleral necrosis remains stable and does not need any further treatment.
Similar content being viewed by others
References
Brady LW, Shields J, Augusburger J, Markoe A, Karlsson UL (1989) Complications from radiation therapy to the eye. Front Radiat Ther Oncol 23:238–250
Corrêa ZM, Augsburger JJ, Freire J, Eagle RC (1999) Early-onset scleral necrosis after iodine I 125 plaque radiotherapy for ciliochoroidal melanoma. Arch Ophthalmol 117:259–261
Gunduz K, Shields CL, Shields JA, Cater J, Freire JE, Brady LW (1999) Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement. Arch Ophthalmol 117:170–177
Shields CL, Naseripour M, Cater J et al (2002) Plaque radiotherapy for large posterior uveal melanomas (≥8 mm thickness) in 354 consecutive patients. Ophthalmology 109:1838–1849
Gunduz K, Shields CL, Shields JA, Cater J, Brady LW (2000) Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension. Am J Ophthalmol 130:97–102
Conway RM, Poothullil AM, Daftari IK, Weinberg V, Chung JE, O’Brien JM (2006) Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy. Arch Ophthalmol 124:838–843
Richtig E, Langmann G, Mullner K, Richtig G, Smolle J (2004) Calculated tumour volume as a prognostic parameter for survival in choroidal melanomas. Eye 18:619–623
Shields CL, Shields JA, Karlsson U, Markoe AM, Brady LW (1989) Reasons for enucleation after plaque radiotherapy for posterior uveal melanoma: clinical findings. Ophthalmology 96:919–923
Starr HJ, Zimmerman LE (1962) Extrascleral extension and orbital recurrence of malignant melanomas of the choroid and ciliary body. Int Ophthalmol Clin 2:369–385
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors have no financial interest in the subject of this paper.
Rights and permissions
About this article
Cite this article
Radin, P.P., Lumbroso-Le Rouic, L., Levy-Gabriel, C. et al. Scleral necrosis after radiation therapy for uveal melanomas: report of 23 cases. Graefes Arch Clin Exp Ophthalmol 246, 1731–1736 (2008). https://doi.org/10.1007/s00417-008-0920-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-008-0920-6